These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 19387120)

  • 1. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron and copper toxicity in diseases of aging, particularly atherosclerosis and Alzheimer's disease.
    Brewer GJ
    Exp Biol Med (Maywood); 2007 Feb; 232(2):323-35. PubMed ID: 17259340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis?
    Lee DW; Andersen JK
    J Neurochem; 2010 Jan; 112(2):332-9. PubMed ID: 20085612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease.
    Floor E
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):709-20. PubMed ID: 10875434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron, brain ageing and neurodegenerative disorders.
    Zecca L; Youdim MB; Riederer P; Connor JR; Crichton RR
    Nat Rev Neurosci; 2004 Nov; 5(11):863-73. PubMed ID: 15496864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
    Eggers AE
    Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear microscope analysis in Alzheimer's and Parkinson's disease: A review.
    Watt F
    Cell Mol Biol (Noisy-le-grand); 1996 Feb; 42(1):17-26. PubMed ID: 8833663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration in normal brain aging and disease.
    Thal DR; Del Tredici K; Braak H
    Sci Aging Knowledge Environ; 2004 Jun; 2004(23):pe26. PubMed ID: 15190177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress.
    Lau FC; Shukitt-Hale B; Joseph JA
    Subcell Biochem; 2007; 42():299-318. PubMed ID: 17612057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
    Mariani E; Polidori MC; Cherubini A; Mecocci P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do alterations in glutathione and iron levels contribute to pathology associated with Parkinson's disease?
    Andersen JK
    Novartis Found Symp; 2001; 235():11-20; discussion 20-5. PubMed ID: 11280021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
    Polidori MC; Griffiths HR; Mariani E; Mecocci P
    Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron in the brain: implications for Parkinson's and Alzheimer's diseases.
    Youdim MB
    Mt Sinai J Med; 1988 Jan; 55(1):97-101. PubMed ID: 3279308
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
    Piñero DJ; Hu J; Connor JR
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):761-76. PubMed ID: 10875438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does cellular iron dysregulation play a causative role in Parkinson's disease?
    Kaur D; Andersen J
    Ageing Res Rev; 2004 Jul; 3(3):327-43. PubMed ID: 15231240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
    Jenner P
    Pathol Biol (Paris); 1996 Jan; 44(1):57-64. PubMed ID: 8734302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain iron accumulation in aging and neurodegenerative disorders.
    Hagemeier J; Geurts JJ; Zivadinov R
    Expert Rev Neurother; 2012 Dec; 12(12):1467-80. PubMed ID: 23237353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.